You just read:

Investor Meetings, New Clinical Data, Closing of Offering, and New Programs - Research Report on Teleflex, Orexigen, Sangamo, InterMune, and ImmunoGen

News provided by

Analysts' Corner

Dec 13, 2013, 08:00 ET